Britain gets ready for rollout of Pfizer's COVID-19 vaccine this week

By Estelle Shirbon and Alistair Smout LONDON (Reuters) - Britain is preparing to become the first country to roll out the Pfizer/BioNTech COVID-19 vaccine this week, initially making the shot available at hospitals before distributing stocks to doctors' clinics, the government said on Sunday. Footage posted by the National Health Service (NHS) showed boxes containing doses of the vaccine being delivered to Croydon University Hospital in south London and being stored in a special, securely locked fridge. 'This is just so exciting

Reuters December 07, 2020 03:10:24 IST
Britain gets ready for rollout of Pfizer's COVID-19 vaccine this week

COVID-19 vaccine this week" src="https://images.firstpost.com/wp-content/uploads/reuters/12-2020/07/2020-12-06T104332Z_2_LYNXMPEGB5005_RTROPTP_2_HEALTH-CORONAVIRUS-BRITAIN-VACCINE.jpg" alt="Britain gets ready for rollout of Pfizers COVID19 vaccine this week" width="300" height="225" />

By Estelle Shirbon and Alistair Smout

LONDON (Reuters) - Britain is preparing to become the first country to roll out the Pfizer/BioNTech COVID-19 vaccine this week, initially making the shot available at hospitals before distributing stocks to doctors' clinics, the government said on Sunday.

Footage posted by the National Health Service (NHS) showed boxes containing doses of the vaccine being delivered to Croydon University Hospital in south London and being stored in a special, securely locked fridge.

"This is just so exciting. It's a momentous occasion," said Louise Coghlan, joint chief pharmacist at the Croydon health service. "To know that they are here and we are much the first in the country to actually receive the vaccine, and therefore the first in the world, is just amazing. I'm so proud."

The first doses are set to be administered on Tuesday, with the NHS giving top priority to vaccinating the over-80s, frontline healthcare workers and care home staff and residents.

Britain gave emergency use approval for the vaccine developed by Pfizer and BioNTech last week - jumping ahead in the global race to begin the most crucial mass inoculation programme in history.

In total, Britain has ordered 40 million doses. As each person requires two doses, that is enough to vaccinate 20 million people in the country of 67 million.

About 800,000 doses are expected to be available within the first week.

Initial doses that have arrived from Belgium are being stored in secure locations across the country, where they will be quality checked, the health ministry said.

The rollout coincides with a crucial and perilous moment in negotiations between Britain and the European Union on a post-Brexit trade agreement.

A status quo transition period will end on Dec. 31 and a no-deal scenario would lead to major disruptions in the movement of goods between Britain and EU countries such as Belgium.

The Observer newspaper reported on Sunday that, under UK government contingency plans, tens of millions of vaccine doses could be flown to Britain by military aircraft to avoid delays at ports caused by Brexit.

The government declined to comment on the Observer report. Farming and environment minister George Eustice, asked on Sky News about concerns of Brexit-related disruption and whether the Observer report was true, said there would be no disruption.

"A huge amount of work has gone on to maintain the flow of goods at the border in the event of there being a no-deal Brexit and we've also got contingency plans in place, including a government-procured ferry that's on standby and of course the option, should it be needed, to use air freight too," he said.

QUEEN TO BE INOCULATED

The Pfizer/BioNTech vaccine needs to be kept at -70C (-94F) and only lasts five days in a regular fridge. For that reason, it will first be administered in 50 hospitals.

NHS England has written to community doctors, telling them to get ready to start giving vaccinations from Dec. 14. Groups of local doctors will operate more than 1,000 vaccination centres across the country, the government said.

Boxes of the vaccine contain five packs of 975 doses, but special regulatory approval is needed to split them up. A senior medical official has said that while he was hopeful it would be possible to split the packs and deliver straight to care homes, it was not guaranteed.

With high levels of vaccine scepticism worrying public health experts, the Times and Mail on Sunday newspapers reported that Queen Elizabeth, 94, and her husband Prince Philip, 99, would "let it be known" when they had received the shot.

The queen is highly admired in British society, and her public backing for the vaccine would be a powerful message to counter anti-vaccination misinformation circulating online.

(Reporting by Alistair Smout and Estelle Shirbon; Editing by Helen Popper and Elaine Hardcastle)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Target holiday sales jump 17% as shoppers splurge online
Business

Target holiday sales jump 17% as shoppers splurge online

By Uday Sampath Kumar (Reuters) - Target Corp reported a 17.2% rise in comparable sales for the holiday season on Wednesday as its online sales more than doubled, thanks to faster deliveries and higher demand for home goods, electronics and beauty products.

S&P 500, Nasdaq tick higher on Intel boost
Business

S&P 500, Nasdaq tick higher on Intel boost

By Medha Singh and Devik Jain (Reuters) - The S&P 500 and the Nasdaq rose in choppy trading on Wednesday as Intel shares jumped thanks to a change in management while broader sentiment was muted after a recent run to record highs. Intel said it would replace Chief Executive Officer Bob Swan with VMware Inc CEO Pat Gelsinger next month

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses
Business

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses

By Danny Ramos LA PAZ (Reuters) - The Bolivian government said on Wednesday it had signed a contract with India's Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine. President Luis Arce said that combined with a recent deal to buy 5.2 million Sputnik V vaccine doses from Russia, Bolivia now expected to be able to inoculate all of its vaccinable population. Both vaccines require two doses to be given, meaning they would be used to inoculate a total of 5.1 million people from Bolivia's 11.51 million-strong population.